Characteristics of patients with systemic sclerosis suffering from a lower limb amputation: Results of a French collaborative study.

Systemic sclerosis amputation lower limb macrovascular disease pulmonary arterial hypertension

Journal

Journal of scleroderma and related disorders
ISSN: 2397-1991
Titre abrégé: J Scleroderma Relat Disord
Pays: England
ID NLM: 101685427

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 22 10 2019
accepted: 16 02 2020
entrez: 6 4 2022
pubmed: 1 10 2020
medline: 1 10 2020
Statut: ppublish

Résumé

Systemic sclerosis mainly affects the microvascular network. However, macrovascular manifestations have been reported. We aimed to investigate the characteristics of systemic sclerosis patients with an amputation of a lower limb segment. We designed a retrospective, case-control, multicentric study on systemic sclerosis patients with amputation of a lower limb segment secondary to critical ischemia via the French Research Group on Systemic Sclerosis. For each case, a control (systemic sclerosis patient without lower limb symptom) was matched with sex, age (±5 years), and cutaneous subset of systemic sclerosis. In total, 26 systemic sclerosis patients (mean age of 67.2 ± 10.9 years, 20 females, 21 limited cutaneous forms) with a lower limb amputation and 26 matched controls (mean age of 67.3 ± 11.2 years, 20 females, 22 limited cutaneous forms) were included. At the time of amputation, the mean disease duration was 12.8 (±8.6) years. In comparison to controls, systemic sclerosis patients with amputation had more digital ulcers (p = 0.048), history of digital ulcers (p = 0.026), and a higher prevalence of pulmonary arterial hypertension (p = 0.024). Systemic sclerosis patients with amputation were more often smokers (p = 0.008) and under corticosteroids (p = 0.015). In the multivariate model, pulmonary arterial hypertension, smoking status, and corticosteroids were independent markers associated with lower limb amputation in systemic sclerosis. In the follow-up, 10 patients (38.5%) had recurrent ischemia requiring a new limb amputation, and five patients (19.2%) had an amputation of the contralateral limb. This study identifies some markers associated with lower limb amputation in systemic sclerosis such as digital ulcers and pulmonary arterial hypertension and points out the high risk associated with tobacco consumption and corticosteroid use.

Identifiants

pubmed: 35382523
doi: 10.1177/2397198320913689
pii: 10.1177_2397198320913689
pmc: PMC8922619
doi:

Types de publication

Journal Article

Langues

eng

Pagination

224-230

Informations de copyright

© The Author(s) 2020.

Déclaration de conflit d'intérêts

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

Arch Phys Med Rehabil. 1992 Sep;73(9):811-3
pubmed: 1514889
Arthritis Rheum. 2011 Jul;63(7):2078-90
pubmed: 21480189
Am J Med. 2013 Nov;126(11):982-8
pubmed: 24157289
Arthritis Res Ther. 2013 Aug 14;15(4):R87
pubmed: 23945149
J Vasc Surg. 2009 Apr;49(4):918-23
pubmed: 19223137
Br J Rheumatol. 1988 Oct;27(5):403-6
pubmed: 3179632
Clin Physiol Funct Imaging. 2010 Nov;30(6):453-9
pubmed: 20718808
Mod Rheumatol. 2014 Jan;24(1):106-11
pubmed: 24261766
Acta Derm Venereol. 2018 Jul 11;98(7):677-682
pubmed: 29648670
J Rheumatol. 1995 Mar;22(3):469-72
pubmed: 7783063
Ann Rheum Dis. 2013 Jul;72(7):1188-93
pubmed: 22904260
Rheumatology (Oxford). 2012 Apr;51(4):735-42
pubmed: 22190687
Br J Dermatol. 2009 Apr;160(4):835-43
pubmed: 19183180
Ann Rheum Dis. 2012 Dec;71(12):1980-3
pubmed: 22532628

Auteurs

Julien Bertolino (J)

Internal Medicine Department, Hôpital Nord, AP-HM, Marseille, France.

Elisabeth Jouve (E)

Medical Evaluation Service, AP-HM, CIC-CPCET, Marseille, France.

Sophie Skopinski (S)

Vascular Medicine Department, Hôpital St André, Bordeaux, France.

Christian Agard (C)

Internal Medicine Department, CHU Nantes, Nantes, France.

Aurélie Achille (A)

Internal Medicine Department, CHU Nantes, Nantes, France.

Benjamin Thoreau (B)

Internal Medicine Department, CHU Tours, Tours, France.

Elisabeth Diot (E)

Internal Medicine Department, CHU Tours, Tours, France.

Sebastien Sanges (S)

University of Lille, U995-LIRIC-Lille Inflammation Research International Center, INSERM, U995, CHU Lille, Internal Medicine and Clinical Immunology Department, Lille, France, Referral Center for Rare Systemic Autoimmune Diseases North and North-West of France, Lille, France.

Sabine Berthier (S)

Internal Medicine and Clinical Immunology Department, CHU Dijon, Dijon, France.

Benjamin Chaigne (B)

Internal Medicine Department, Reference Center for Rare Systemic Autoimmune Diseases of Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

Alexis Régent (A)

Internal Medicine Department, Reference Center for Rare Systemic Autoimmune Diseases of Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

Thierry Martin (T)

Clinical Immunology Department, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Gregory Pugnet (G)

Internal Medicine Department, Hôpital Purpan, CHU Toulouse, Toulouse, France.

Audrey Benyamine (A)

Internal Medicine Department, Hôpital Nord, AP-HM, Marseille, France.

Pascal Rossi (P)

Internal Medicine Department, Hôpital Nord, AP-HM, Marseille, France.

David Launay (D)

University of Lille, U995-LIRIC-Lille Inflammation Research International Center, INSERM, U995, CHU Lille, Internal Medicine and Clinical Immunology Department, Lille, France, Referral Center for Rare Systemic Autoimmune Diseases North and North-West of France, Lille, France.

Luc Mouthon (L)

Internal Medicine Department, Reference Center for Rare Systemic Autoimmune Diseases of Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

Brigitte Granel (B)

Internal Medicine Department, Hôpital Nord, AP-HM, Marseille, France.

Classifications MeSH